Click Therapeutics

Click Therapeutics, Inc. is a New York-based company that specializes in the development and commercialization of digital therapeutics designed to address unmet medical needs through cognitive and neurobehavioral modification. Founded in 2012, the company creates software-based prescription treatments for various conditions, including smoking cessation, major depressive disorder, schizophrenia, insomnia, and chronic pain. Its innovative Digital Therapeutics™ are intended to be utilized independently or alongside traditional biomedical approaches. The company employs its Clickometrics® adaptive data science platform to tailor user experiences and enhance engagement and treatment outcomes. Following successful clinical trials, Click's smoking cessation program is now accessible nationwide through various healthcare payers, providers, and employers. Additionally, Click Therapeutics is advancing its lead prescription program into a phase III FDA registration trial for the treatment of major depressive disorder in adults.